Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma.

MLA

Murakami, S., et al. “Caveolin-I Overexpression Is a Favourable Prognostic Factor for Patients with Extrahepatic Bile Duct Carcinoma.” British Journal of Cancer, vol. 88, no. 8, Apr. 2003, p. 1234. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=9994843&authtype=sso&custid=ns315887.

APA

Murakami, S., Miyamoto, M., Hida, Y., Cho, Y., Fukunaga, A., Oshikiri, T., Kato, K., Kurokawa, T., Suzuoki, M., Nakakubo, Y., Hiraoka, K., Itoh, T., Shinohara, T., Morikawa, T., Okushiba, S., Kondo, S., & Katoh, H. (2003). Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma. British Journal of Cancer, 88(8), 1234.

Chicago

Murakami, S., M. Miyamoto, Y. Hida, Y. Cho, A. Fukunaga, T. Oshikiri, K. Kato, et al. 2003. “Caveolin-I Overexpression Is a Favourable Prognostic Factor for Patients with Extrahepatic Bile Duct Carcinoma.” British Journal of Cancer 88 (8): 1234. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=9994843&authtype=sso&custid=ns315887.